MTOR and renal cell carcinoma: Nevertheless, descriptive heatmaps for molecular pathways, including angiogenesis and PI3K-AKT-mTOR signaling, known to be involved in RCC, were mandatory for designing specific biomarker or drug testing studies with novel drug candidates.